The application of microarray technology to neuropathology: Cutting edge tool with clinical diagnostics potential or too much information?

Journal of Neuropathology and Experimental Neurology

Volumn 65, Issue 11, 2006, Pages 1031-1039

  McShea, Andrew ^b   Marlatt, Michael W ^a,c   Lee, Hyoung Gon ^a   Tarkowsky, Stephanie M ^a   Smit, Mariya ^b   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Combimatrix Corporation ^*  (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Alzheimer disease; Dementia; Diagnostics; Microarray; Neurofibrillary tangles; Tau

Indexed keywords

ALZHEIMER DISEASE; COGNITIVE DEFECT; DISEASE COURSE; DNA DAMAGE; DNA MICROARRAY; DNA REPAIR; GENOTYPE; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 33750599514     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jnen.0000240471.04920.3c     Document Type: Review

References (52)

1. Stokin GB, Lillo C, Falzone TL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005;307:1282-88
2. Yao PJ, Zhu M, Pyun EI, et al. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol Dis 2003;12:97-109
3. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SH. Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol 1988;132:86-101
4. Dickson DW, Crystal HA, Mattiace LA, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1992;13:179-89
5. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705
6. Smith CD, Carney JM, Tatsumo T, Stadtman ER, Floyd RA, Markesbery WR. Protein oxidation in aging brain. Ann N Y Acad Sci 1992;663:110-19
7. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997;17:2653-57
8. Zhu X, Raina AK, Smith MA. Cell cycle events in neurons. Proliferation or death? Am J Pathol 1999;155:327-29
9. Webber KM, Bowen R, Casadesus G, Perry G, Atwood CS, Smith MA. Gonadotropins and Alzheimer's disease: The link between estrogen replacement therapy and neuroprotection. Acta Neurobiol Exp (Wars) 2004;64:113-18
10. Bowen RL, Smith MA, Harris PL, et al. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res 2002;70:514-18
11. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997;20:154-59
12. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002;298:789-91
13. Pollack JR, Perou CM, Alizadeh AA, et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999;23:41-46
14. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ. High-density synthetic oligonucleotide arrays. Nat Genet 1999;21:20-24
15. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A 1996;93:10614-19
16. Drobyshev AL, Machka C, Horsch M, et al. Specificity assessment from fractionation experiments (SAFE): A novel method to evaluate microarray probe specificity based on hybridisation stringencies. Nucleic Acids Res 2003;31:E1-1
17. Yang IV, Chen E, Hasseman JP, et al. Within the fold: Assessing differential expression measures and reproducibility in microarray assays. Genome Biol 2002;3:research0062. Epub Oct 24, 2002
18. Kuo WP, Jenssen TK, Butte AJ, Ohno-Machado L, Kohane IS. Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics 2002;18:405-12
19. Shi L, Tong W, Fang H, et al. Cross-platform comparability of microarray technology: Intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics 2005;6(suppl 2):S12
20. Hanzel DK, Trojanowski JQ, Johnston RF, Loring JF. High-throughput quantitative histological analysis of Alzheimer's disease pathology using a confocal digital microscanner. Nat Biotechnol 1999;17:53-57
21. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine JH. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci U S A 1990;87:1663-67
22. Nunomura A, Chiba S, Lippa CF, et al. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol Dis 2004;17:108-13
23. Nunomura A, Chiba S, Kosaka K, et al. Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies. Neuroreport 2002;13:2035-39
24. Nunomura A, Perry G, Pappolla MA, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 1999;19:1959-64
25. Shi L, Tong W, Su Z, et al. Microarray scanner calibration curves: Characteristics and implications. BMC Bioinformatics 2005;6(suppl 2):S11
26. Miller RA, Galecki A, Shmookler-Reis RJ. Interpretation, design, and analysis of gene array expression experiments. J Gerontol A Biol Sci Med Sci 2001;56:B52-57
27. Blalock EM, Chen KC, Sharrow K, et al. Gene microarrays in hippocampal aging: Statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 2003;23:3807-19
28. Vastag B. Gene chips inch toward the clinic. JAMA 2003;289:155-69
29. Weigelt B, Hu Z, He X, et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res 2005;65:9155-58
30. Smith MW, Yue ZN, Geiss GK, et al. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res 2003;63:859-64
31. Ginsberg SD, Hemby SE, Lee VM, Eberwine JH, Trojanowski JQ. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 2000;48:77-87
32. Prtilo A, Leach FS, Markwalder R, et al. Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer. J Urol 2005;174:1814-18; discussion 18
33. Poola I, DeWitty RL, Marshalleck JJ, Bhatnagar R, Abraham J, Leffall LD. Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis. Nat Med 2005;11:481-83
34. Kalman J, Palotas A, Juhasz A, et al. Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression - Evolution of antidepressants and the role of the 'neuro-immune' system. Neurochem Res 2005;30:1429-38
35. Rokutan K, Morita K, Masuda K, et al. Gene expression profiling in peripheral blood leukocytes as a new approach for assessment of human stress response. J Med Invest 2005;52:137-44
36. Kalman J, Kitajka K, Pakaski M, et al. Gene expression profile analysis of lymphocytes from Alzheimer's patients. Psychiatr Genet 2005;15:1-6
37. Emilsson L, Saetre P, Jazin E. Low mRNA levels of RGS4 splice variants in Alzheimer's disease: Association between a rare haplotype and decreased mRNA expression. Synapse 2006;59:173-76
38. Walker PR, Smith B, Liu QY, et al. Data mining of gene expression changes in Alzheimer brain. Artif Intell Med 2004;31:137-54
39. Moran LB, Duke DC, Deprez M, Dexter DT, Pearce RK, Graeber MB. Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics 2006;7:1-11
40. Xiang W, Windl O, Westner IM, et al. Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease. Ann Neurol 2005;58:242-57
41. Altar CA, Jurata LW, Charles V, et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 2005;58:85-96
42. Lu T, Pan Y, Kao SY, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004;429:883-91
43. Walker DG, Link J, Lue LF, Dalsing-Hernandez JE, Boyes BE. Gene expression changes by amyloid beta peptide-stimulated human post-mortem brain microglia identify activation of multiple inflammatory processes. J Leukoc Biol 2006;79:596-610
44. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A 2004;101:2173-78
45. Bachoo RM, Kim RS, Ligon KL, et al. Molecular diversity of astrocytes with implications for neurological disorders. Proc Natl Acad Sci U S A 2004;101:8384-89
46. Wu ZL, Ciallella JR, Flood DG, O'Kane TM, Bozyczko-Coyne D, Savage MJ. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease. Neurobiol Aging 2006;27:377-86
47. Sakamoto M, Kondo A, Kawasaki K, et al. Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray. Hum Cell 2001;14:305-15
48. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-47
49. Davidsson P, Sjogren M. The use of proteomics in biomarker discovery in neurodegenerative diseases. Dis Markers 2005;21:81-92
50. Palotas A, Puskas LG, Kitajka K, et al. Altered response to mirtazapine on gene expression profile of lymphocytes from Alzheimer's patients. Eur J Pharmacol 2004;497:247-54
51. Palotas A, Puskas LG, Kitajka K, et al. The effect of citalopram on gene expression profile of Alzheimer lymphocytes. Neurochem Res 2004;29:1563-70
52. Nelson PT, Baldwin DA, Kloosterman WP, Kauppinen S, Plasterk RH, Mourelatos Z. RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA 2006;12:187-91